Skip to main content
. 2018 Aug 1;62(4):438–445. doi: 10.20945/2359-3997000000060

Figure 1. Effect of different drug groups on bone turnover markers in postmenopausal women with osteoporosis.

Figure 1

* = p < 0.05: end level compared with initial of study in control group. € = p < 0.05: end level compared with initial of study in alendronate.

# = p < 0.05: end level compared with end of study in alendronate + curcumin group.

BALP: bone-specific alkaline phosphatase, CTx: C-terminal cross-linking telopeptide of type I collagen.